Kobiolabs
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kobiolabs - overview
Established
2014
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Founded in 2014 and based in Seoul, South Korea, Kobiolabs is a biotechnology company that focuses on developing microbiome therapeutics for immune, metabolic and neurological. The diff infection program, atopic dermatitis program, and chronic kidney disease program are selected as the government-sponsored project in 2017. The candidate drug for psoriasis, KBLP-001 phases 1 study HREC approve in 2019, and phase 1 study completed in May 2020. The candidate drug for Inflammatory Bowel Disease (IBD) was initiated in April 2020 and received phase two study approval from the US in July 2021.
The company was listed on the KOSDAQ stock market in November 2020. The company engages in microbiome therapeutics for immune, metabolic and neurological. The new drug development pipeline has entered clinical phases including candidates for drugs for psoriasis, asthma, and IBD. And the candidate's drugs for immune-oncology, liver disease, autism spectrum disorder non-alcoholic steatohepatitis are in the development phase.
Current Investors
E-mart, IBK Capital, CKD Venture Capital
Primary Industry
Biotechnology
Sub Industries
Biopolymers, Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.kobiolabs.com
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Kobiolabs - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Direct, PIPE | Completed | Kobiolabs | - | ||||||||
| PIPE | Completed | Kobiolabs | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.